Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Signal Transduction and Targeted Therapy|April 14, 2021
Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degenerationSiddharth Narendran, Felipe Pereira, Praveen Yerramothu, et al.Indian Journal of Ophthalmology|June 27, 2020
Ocular oncology practice guidelines during COVID-19 pandemic-An expert consensusFairooz P Manjandavida, Santosh G Honavar, Usha Kim, et al.Indian Journal of Ophthalmology|July 28, 2025
Lag time for diagnosis and treatment in 1120 retinoblastoma children: Analysis from InPOG-RB-19-01Sima Das, Rachna Meel, Amita Mahajan, et al.Science Immunology|December 3, 2021
DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAsShao-Bin Wang, Siddharth Narendran, Shuichiro Hirahara, et al.Nature Communications|September 24, 2020
Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes developmentJayakrishna Ambati, Joseph Magagnoli, Hannah Leung, et al.Nature Medicine|November 28, 2017
cGAS drives noncanonical-inflammasome activation in age-related macular degenerationNagaraj Kerur, Shinichi Fukuda, Daipayan Banerjee, et al.Science Advances|September 29, 2021
<i>Alu</i> complementary DNA is enriched in atrophic macular degeneration and triggers retinal pigmented epithelium toxicity via cytosolic innate immunityShinichi Fukuda, Siddharth Narendran, Akhil Varshney, et al.Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
Cytoplasmic synthesis of endogenous <i>Alu</i> complementary DNA via reverse transcription and implications in age-related macular degenerationShinichi Fukuda, Akhil Varshney, Benjamin J Fowler, et al.Indian Journal of Ophthalmology|June 22, 2021
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1Mrittika Sen, Santosh G Honavar, Rolika Bansal, et al.JAMA Oncology|February 28, 2020
Global Retinoblastoma Presentation and Analysis by National Income Level, Ido Didi Fabian, Elhassan Abdallah, et al.Pageof 8